ISPE 2026 年会：Lonza CEO Wolfgang Wienand 主题演讲探讨明日药品的规模化制造

iSpeak Blog

13 October 2026

Scientific innovation continues to accelerate across the pharmaceutical and biopharmaceutical industries. From biologics and antibody-drug conjugates to cell and gene therapies, mRNA technologies, and radiopharmaceuticals, new treatment modalities are creating opportunities to address some of the world's most challenging diseases. Yet scientific discovery is only part of the journey. Ensuring these innovations reach patients requires manufacturing systems, supply chains, regulatory strategies, and operational models capable of supporting increasingly complex therapies at scale.

These opportunities and challenges will be a central focus of the 2026 ISPE Annual Meeting & Expo, taking place 18-21 October in Washington, D.C., USA, and virtually. Bringing together pharmaceutical and biopharmaceutical professionals from across the globe, the event will provide a forum for industry-critical discussions on the technologies, practices, and partnerships shaping the future of medicines.

Among the featured keynote sessions, "The Lonza Engine: Manufacturing the Medicines of Tomorrow," presented by Wolfgang Wienand, PhD, CEO of Lonza, will explore how the industry is adapting to meet growing demand for advanced therapies while maintaining high standards of quality, reliability, and supply continuity.

Navigating a New Era of Pharmaceutical Manufacturing

Today's pharmaceutical landscape is characterized by rapid innovation alongside increasing complexity. Organizations must navigate evolving regulatory expectations, global supply chain considerations, geopolitical influences, and the challenges associated with commercializing new therapeutic modalities.

As highlighted in a preview video for the upcoming session, the industry increasingly understands how to treat many serious diseases. However, bringing these therapies to patients remains a significant undertaking. Success requires thoughtful integration of manufacturing, quality, regulatory, and supply chain considerations throughout development and commercialization.

During his keynote, Wienand will share perspectives on the role contract development and manufacturing organizations (CDMOs) play in helping transform scientific breakthroughs into therapies that can be reliably produced and delivered to patients around the world. Drawing on experiences from across the industry, the session will examine the capabilities, partnerships, and operating models needed to address growing demand for innovative medicines.

Attendees can expect discussions around:

Scaling manufacturing to support emerging therapeutic modalities
Building resilient and competitive global manufacturing networks
Strengthening supply continuity in a rapidly evolving environment
Integrating development, quality, and commercialization strategies
Supporting innovation while maintaining operational excellence

The session will also explore how CDMOs are adapting to manage increasing product complexity while balancing efficiency, compliance, and patient needs.

Themes That Span the Industry

Wienand's keynote will address challenges that extend across the pharmaceutical and biopharmaceutical landscape. Topics such as scaling advanced therapies, strengthening supply chain resilience, maintaining quality and reliability, navigating increasing complexity, and preparing for future manufacturing demands are central concerns for organizations throughout the industry.

These themes connect with many of the discussions taking place throughout the 2026 ISPE Annual Meeting & Expo, where attendees will explore the scientific, operational, digital, regulatory, and workforce considerations shaping the future of pharmaceutical manufacturing and patient access.

Exploring the Future of Pharmaceutical Manufacturing

The 2026 ISPE Annual Meeting & Expo agenda is organized around five educational tracks designed to examine the interconnected challenges and opportunities facing the industry:

Digital, Data, and Decision Integrity: Explore how organizations are using digital technologies, trusted data, advanced analytics, and artificial intelligence to support compliant operations and informed decision-making in regulated environments.
From Breakthrough to Bedside: Examine how innovative medicines across a growing range of modalities can be developed, manufactured, scaled, and delivered to patients more efficiently and effectively.
Governance, Risk, and Readiness: Learn how industry and regulatory leaders are approaching evolving quality, compliance, inspection, and risk-management challenges in an era of rapid technological advancement.
People, Capability, and the Workforce of Delivery: Discover strategies for building workforce capabilities, addressing evolving skill requirements, and fostering effective collaboration between people and emerging technologies.
Systems That Deliver Reliably: Explore approaches that integrate facilities, manufacturing, quality, supply chain, and sustainability into resilient systems that support reliable patient access to therapies.

Together, these tracks provide opportunities to learn from industry experts, regulators, and peers through technical presentations, case studies, panel discussions, and practical examples.

Join the Conversation

The 2026 ISPE Annual Meeting & Expo is more than a technical conference. It is a gathering place for professionals across drug manufacturing, engineering, quality, supply chain, regulatory affairs, digital transformation, equipment, and services to exchange ideas and explore solutions to shared challenges.

In addition to keynote presentations, attendees will have access to cutting-edge technical sessions, interactive workshops, networking opportunities, regulatory discussions, and an expansive Expo Hall showcasing emerging technologies and services supporting the life sciences industry.

For professionals focused on advancing innovation while ensuring therapies can be manufactured, scaled, and delivered effectively, Wienand's keynote will provide valuable perspectives on some of the most pressing issues facing the industry today.

Learn more and register for the conference>

About the Author

Shape the Future of Pharma

ISPE delivers technical and operational solutions to support across the global pharmaceutical and biopharmaceutical industry in the manufacture of quality medicines for patients.